What Happened?
Houston, TX-based Esperance-Pharmaceuticals Appointed Hector Alila as President and Chief Executive Officer
About the Company
Esperance Pharmaceuticals, Inc. is developing a new class of targeted oncology products that selectively kill cancer cells without harming normal cells. Targeting occurs through binding to specific receptors on the cancer cell surface. The novel product candidates destroy dividing and non-dividing cancer cells including those known to be resistant to chemotherapeutics.
About the Person
Hector Alila is President and Chief Executive Officer at Esperance Pharmaceuticals. Previously, Hector held various senior HR leadership roles in the industry.Hector Alila is President and Chief Executive Officer at Esperance Pharmaceuticals. Previously, Hector held various senior HR leadership roles in the industry.
Info Source
Press Release
Short Profile